RCS - Agronomics Limited - Meatable acquires Meat Technology platform

AgronomicsAnnouncement

22/08/2025 08:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250822:nRSV4229Wa&default-theme=true

RNS Number : 4229W  Agronomics Limited  22 August 2025

22 August 2025

 Agronomics (https://agronomics.im/) Limited

("Agronomics" or the "Company")

Meatable Strengthens Position in Cultivated Meat Market with Acquisition of
Uncommon Bio's Cultivated Meat Technology Platform

Agronomics (LSE: ANIC), a leading listed company in the field of clean food,
is pleased to announce that its portfolio company,  Meatable B.V.
("Meatable") has announced the acquisition of Uncommon Bio Limited's
("Uncommon") cultivated meat platform. This includes key technology, several
intellectual property assets and high performing cell lines, and expert staff.
This acquisition advances Meatable's competitive positioning within the
sector, providing enhanced operational capacity and expanded technological
capabilities for commercial-scale cultivated protein production.

Jim Mellon, Executive Chair of Agronomics, commented: "With this acquisition,
Meatable is reinforcing its position as a global leader in cultivated meat,
proving what is possible when the world's sharpest minds address one of our
greatest challenges: feeding a growing planet amid rising meat demand and
shrinking supply.

By combining Uncommon's platform with its own, Meatable will have an enviable
offering for prospective customers, offering greater choice and scalability,
and answering the global call for a protein supply chain which can help
moderate  price volatility, and boost food security."

To date, Agronomics has invested a total of £7.9 million in Meatable which,
subject to audit, is currently carried at £11.7 million. This position
represents c.8.10% of Agronomics' last stated Net Asset Value as at 30 June
2025.

The full announcement is set out below without any material changes:

Meatable Cements Global Leadership in Sustainable Meat with Acquisition of
Uncommon Bio's Cultivated Meat Platform

Leiden, August 21, 2025 - Meatable, a global leader in cultivated meat
technology, today announced the transformative acquisition of Uncommon Bio's
cultivated meat platform, including key technology, several intellectual
property assets and high performing cell lines, and expert staff. This
acquisition propels Meatable into an unmatched position in the field, offering
the most comprehensive, agile, and market-ready cultivated meat capabilities
in the industry.

With the integration of Uncommon Bio's cutting-edge non-GMO mRNA reprogramming
and saRNA differentiation technologies, Meatable now operates the only true
multi-platform cultivated meat technology offering. This versatile solution,
pairing Meatable's use of the patented opti-ox™ system with Uncommon Bio's
technological capabilities, equips the company to accelerate time to market,
navigate regulatory pathways worldwide, and adapt swiftly to diverse consumer
and cultural preferences.

"I'm incredibly proud of what we've built at Uncommon Bio, a legacy of
innovation and bold thinking in cultivated meat," said Benjamina Bollag, CEO
of Uncommon. "After deciding to focus on therapeutics, we wanted to find the
best home for our technology and it's exciting to see Meatable carry our
work  forward and apply it at scale. I look forward to  continuing our
collaboration and watching their continued success and global impact in the
years ahead."

"This acquisition is more than a strategic step - it sets a new standard for
cultivated meat production," said Jeff Tripician, CEO of Meatable. "By
combining two highly complementary platforms, Meatable is now equipped to
reliably deliver high-quality cultivated meat at a global scale. This enables
us to support the meat industry with a stable, secure, and future-proof supply
of species like pork, beef, lamb, and poultry, ensuring business continuity
and resilience in the face of increasingly uncertain times."

Already recognized for its pioneering work in cultivated pork and beef,
Meatable is now positioned to expand rapidly across species, markets, and
consumer segments. The addition of Uncommon Bio's technology accelerates
product development for chicken, lamb, and high-flavor breeds, while its
non-GMO status and regulatory ready dossier support faster regulatory approval
in multiple regions. The acquisition also strengthens Meatable's intellectual
property portfolio with additional patents and proprietary assets, further
consolidating its status as a technological leader in cellular agriculture.

Positioned as an integral part of the global meat industry, Meatable is
forging partnerships across the supply chain to complement, rather than
replace, traditional livestock producers. As the demand for meat continues to
grow, the company's goal is to help supply additional meat to the meat
industry on a global level, and doing so efficiently, at scale and without any
risk of livestock disease. Achieving that impact requires bold,
out‑of‑the‑box thinking and a willingness to incorporate external
knowledge and technologies - principles embodied in the Uncommon Bio
acquisition.

"The value of the IP is strengthened by the caliber of investors who have
supported Uncommon's mission from the start," said Aris de Rijke, CTO at
Meatable. "We're proud to carry forward technology that has earned the trust
of such respected backers, like Apollo Projects and Lower Carbon Capital,
further fueling our path toward success at scale."

With its broadened base of IP, cell lines, and applications, Meatable now
becomes the only cultivated meat company with a true multi-platform strategy -
engineered for versatility, speed, and market relevance. The company is
uniquely positioned to deliver sustainable, great-tasting meat to feed a
hungry planet.

About Meatable

Meatable is leading the charge in revolutionizing how the meat industry
sources and produces meat. It is a vendor-partner to the meat industry and
provides the science and technology to sustainably produce affordable,
great-tasting, real meat at scale. Meatable's cultivated meat technology is
designed to complement and integrate into the existing traditional meat
industry's supply chains, offering opportunities for partnerships that
strengthen the entire system. It accomplishes this without harming animals or
the planet, 25x times faster than traditional protein. It is the solution for
feeding a hungry planet in the future.

About Agronomics

Agronomics is a leading London-listed company focusing on investment
opportunities within the field of clean food. The Company has established a
portfolio of over 20 companies in this rapidly advancing sector. It seeks to
invest in companies owning technologies with defensible intellectual property
that offer new ways of producing food and materials with a focus on products
historically derived from animals.

These technologies are driving a major disruption in agriculture, offering
solutions to improve sustainability, as well as addressing human health,
animal welfare and environmental damage. This disruption will decouple supply
chains from the environment and animals and improve food security for the
world's expanding population. A full list of Agronomics' portfolio companies
is available at (https://agronomics.im/) https://agronomics.im/
(https://agronomics.im/) .

For further information, please contact:

 Agronomics Limited   Beaumont Cornish Limited  Canaccord Genuity Limited  Cavendish Capital Markets Limited  Peterhouse Capital Limited  33Seconds Limited
 The Company          Nomad                     Joint Broker               Joint Broker                       Joint Broker                Public Relations
 Jim Mellon           Roland Cornish            Andrew Potts               Giles Balleny                      Lucy Williams               Jack Ferris

 Denham Eke           James Biddle              Harry Pardoe               Michael Johnson                    Charles Goodfellow          Calum Warren-Piper

 +44 (0) 1624 639396  +44 (0) 207 628 3396      +44 (0) 207 523 8000       +44 (0) 207 397 8900               +44 (0) 207 469 0936        agronomics@33seconds.co

 info@agronomics.im

About Reach announcements

 

This is a Reach announcement. Reach is an investor communication service aimed
at assisting listed and unlisted (including AIM quoted) companies to
distribute media only / non-regulatory news releases into the public domain.
Information required to be notified under the AIM Rules for Companies, Market
Abuse Regulation or other regulation would be disseminated as an RNS
regulatory announcement and not on Reach.

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAPTMRTMTBTMFA